FDA Inspection 1218715 — Memorial Sloan Kettering Cancer Center IRB
The FDA completed an inspection of Memorial Sloan Kettering Cancer Center IRB on September 15, 2023 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
IRB